+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biomarkers Market - Global Forecast 2026-2032- Product Image
Biomarkers Market - Global Forecast 2026-2032- Product Image
New

Biomarkers Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 196 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6082615
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global biomarkers market is rapidly advancing, driven by innovations that are fundamentally reshaping early disease detection, personalized medicine, and operational models across healthcare. As industry standards evolve, senior decision-makers require practical intelligence to maneuver amid changing regulations, technology paradigms, and collaborative networks.

Market Snapshot: Biomarkers Market Size, Growth, and Outlook

The biomarkers market is experiencing robust growth, with a value of USD 68.08 billion in 2025 and expanding to USD 77.73 billion in 2026. Sustaining a CAGR of 14.72%, the industry is on course to achieve USD 178.08 billion by 2032. Key growth drivers include widespread adoption of next-generation diagnostic tools, strategic partnerships between technology innovators and life sciences companies, and rising global demand for precision medicine solutions. This market trajectory highlights significant opportunities for organizations aiming to harness leading-edge molecular diagnostics, accelerated clinical decision-making, and scalable biomarker-enabled applications.

Scope & Segmentation: Comprehensive Coverage of the Biomarkers Market

  • Sample Sources: Blood, including plasma and serum, remains central for detecting proteins, metabolites, and nucleic acids. Saliva, tissue, and urine are important for enabling non-invasive, localized, and high-scale screening workflows tailored to diverse operational needs.
  • Technologies: Immunoassays—such as chemiluminescent platforms, ELISA, and lateral flow assays—complement advanced mass spectrometry methods, including GC-MS, LC-MS, and MALDI-TOF. Digital PCR, qPCR, as well as next-generation and Sanger sequencing platforms, enrich analytic capabilities.
  • Biomarker Types: Cellular (functional assays), genetic (covering both DNA and RNA modalities), metabolomic (real-time biochemical marker tracking), and protein-based markers each provide essential perspectives for both research and clinical deployment.
  • Applications: Uses extend from clinical diagnostics and therapeutic monitoring to supporting drug discovery validation and personalized medicine strategy implementation, creating value across R&D and healthcare delivery sectors.
  • End Users: Academic research organizations, diagnostic laboratories, hospitals, and pharmaceutical companies all deploy biomarker platforms across varied workflows, enabling enhanced patient stratification and optimized resource allocation.
  • Geographies: Detailed market analysis covers the Americas, Europe, Middle East & Africa, and Asia-Pacific. The segmentation reflects distinct regional priorities, addressing the requirements of both established and emerging healthcare ecosystems.

Key Takeaways: Strategic Insights for Leaders

  • Multi-omics approaches and artificial intelligence are fundamentally transforming biomarker discovery and clinical development, enabling greater accuracy in disease profiling and promoting evidence-based decisions at the point of care.
  • Strong partnerships among platform developers, bioinformatics providers, and pharmaceutical stakeholders help streamline data integration, improving workflow turnaround and supporting multi-disciplinary research initiatives.
  • Automation and digital health capabilities increase operational agility by enhancing sample processing, enabling remote patient monitoring, and allowing for real-time biomarker data collection.
  • Use of diverse sample types and advanced assay technologies supports expansion into minimally invasive diagnostics and facilitates comprehensive patient stratification strategies.
  • Stakeholder collaboration leverages genomic sequencing, mass spectrometry, and mobile health platforms to drive scalable biomarker innovation, with global clinical impact benefiting populations across regions.

Tariff Impact: Navigating Supply Chain Shifts

New United States tariffs introduced in 2025 affected cost structures and sourcing timelines for biomarker research products globally. To ensure business continuity, organizations diversified their supplier base, pursued relationships with both domestic and alternative international vendors, and invested in local alliances for shared operational risk management. Enhanced risk assessment protocols and scenario planning have resulted in more flexible supply chains, increasing readiness for further policy changes and maintaining ongoing market adaptability.

Methodology & Data Sources

This analysis is built on primary interviews with market experts, in-depth literature reviews, and examination of secondary sources such as corporate filings and patent databases. Internal peer reviews, supplemented by external specialist validation, enhance the accuracy and rigor of the presented findings.

Why This Report Matters: Decision-Driven Market Intelligence

  • Facilitates strategic planning by distilling actionable insights across market entry, product positioning, and portfolio investment in the biomarkers sector.
  • Prepares leaders to anticipate and mitigate supply chain and compliance risks through benchmarking of sourcing strategies and cross-sector collaboration.
  • Equips organizations to optimize technology adoption and streamline pipeline progression, supporting faster clinical translation and stronger competitive positioning.

Conclusion

The biomarkers sector is defined by digital transformation, collaborative partnerships, and agile supply chain strategies. Senior decision-makers who prioritize integration and operational resilience will be well-placed for sustained growth within an evolving market landscape.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Biomarkers Market, by Biomarker Source
8.1. Blood
8.1.1. Plasma
8.1.2. Serum
8.2. Saliva
8.3. Tissue
8.4. Urine
9. Biomarkers Market, by Technology
9.1. Immunoassay
9.1.1. Chemiluminescent Immunoassay
9.1.2. Elisa
9.1.3. Lateral Flow Assay
9.2. Mass Spectrometry
9.2.1. Gas Chromatography Mass Spectrometry
9.2.2. Liquid Chromatography Mass Spectrometry
9.2.3. Matrix Assisted Laser Desorption Ionization Time Of Flight
9.3. Polymerase Chain Reaction
9.3.1. Digital Polymerase Chain Reaction
9.3.2. Quantitative Polymerase Chain Reaction
9.4. Sequencing
9.4.1. Next Generation Sequencing
9.4.2. Sanger Sequencing
10. Biomarkers Market, by Biomarker Type
10.1. Cellular Biomarkers
10.2. Genetic Biomarkers
10.2.1. DNA Biomarkers
10.2.2. RNA Biomarkers
10.3. Metabolomic Biomarkers
10.4. Protein Biomarkers
11. Biomarkers Market, by Application
11.1. Clinical Trials
11.2. Diagnostics
11.3. Drug Discovery
11.4. Personalized Medicine
12. Biomarkers Market, by End User
12.1. Academic And Research Institutes
12.2. Diagnostic Laboratories
12.3. Hospitals
12.4. Pharmaceutical Companies
13. Biomarkers Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Biomarkers Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Biomarkers Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Biomarkers Market
17. China Biomarkers Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Alto Neuroscience,Inc.
18.7. APIS Assay Technologies Limited
18.8. Augurex Life Sciences Corp
18.9. Bio-Rad Laboratories, Inc.
18.10. BioAgilytix
18.11. Biocrates Life Sciences AG
18.12. Biofourmis Inc.
18.13. Biognosys AG
18.14. BIOINFRA Life Science Inc.
18.15. BioStarks
18.16. BioVision Inc.
18.17. Charles River Laboratories, Inc.
18.18. Clarigent Corporation
18.19. EKF Diagnostics Holdings PLC
18.20. Elo Health, Inc.
18.21. F. Hoffmann-La Roche, Ltd.
18.22. Merck KgaA
18.23. Nightingale Health Plc
18.24. Owkin Inc.
18.25. Owlstone Medical Limited
18.26. PerkinElmer, Inc.
18.27. Personalis, Inc.
18.28. Proteomedix AG
18.29. QIAGEN GmbH
18.30. Renalytix PLC
18.31. Siemens Healthcare GmbH
18.32. Sino Biological Inc.
18.33. Thermo Fisher Scientific, Inc.
18.34. VivoSense, Inc.
List of Figures
FIGURE 1. GLOBAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIOMARKERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BIOMARKERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIOMARKERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BIOMARKERS MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BIOMARKERS MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BIOMARKERS MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BIOMARKERS MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BIOMARKERS MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BIOMARKERS MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BIOMARKERS MARKET SIZE, BY SERUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BIOMARKERS MARKET SIZE, BY SERUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BIOMARKERS MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BIOMARKERS MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BIOMARKERS MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BIOMARKERS MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BIOMARKERS MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BIOMARKERS MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BIOMARKERS MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BIOMARKERS MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BIOMARKERS MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BIOMARKERS MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BIOMARKERS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BIOMARKERS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BIOMARKERS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BIOMARKERS MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BIOMARKERS MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BIOMARKERS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BIOMARKERS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BIOMARKERS MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BIOMARKERS MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BIOMARKERS MARKET SIZE, BY GAS CHROMATOGRAPHY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BIOMARKERS MARKET SIZE, BY GAS CHROMATOGRAPHY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BIOMARKERS MARKET SIZE, BY GAS CHROMATOGRAPHY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BIOMARKERS MARKET SIZE, BY LIQUID CHROMATOGRAPHY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BIOMARKERS MARKET SIZE, BY LIQUID CHROMATOGRAPHY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BIOMARKERS MARKET SIZE, BY LIQUID CHROMATOGRAPHY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BIOMARKERS MARKET SIZE, BY MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BIOMARKERS MARKET SIZE, BY MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BIOMARKERS MARKET SIZE, BY MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BIOMARKERS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BIOMARKERS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BIOMARKERS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BIOMARKERS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BIOMARKERS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BIOMARKERS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BIOMARKERS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BIOMARKERS MARKET SIZE, BY SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BIOMARKERS MARKET SIZE, BY SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BIOMARKERS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BIOMARKERS MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BIOMARKERS MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BIOMARKERS MARKET SIZE, BY CELLULAR BIOMARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BIOMARKERS MARKET SIZE, BY CELLULAR BIOMARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BIOMARKERS MARKET SIZE, BY CELLULAR BIOMARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BIOMARKERS MARKET SIZE, BY DNA BIOMARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BIOMARKERS MARKET SIZE, BY DNA BIOMARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BIOMARKERS MARKET SIZE, BY DNA BIOMARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BIOMARKERS MARKET SIZE, BY RNA BIOMARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BIOMARKERS MARKET SIZE, BY RNA BIOMARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BIOMARKERS MARKET SIZE, BY RNA BIOMARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BIOMARKERS MARKET SIZE, BY METABOLOMIC BIOMARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BIOMARKERS MARKET SIZE, BY METABOLOMIC BIOMARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BIOMARKERS MARKET SIZE, BY METABOLOMIC BIOMARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BIOMARKERS MARKET SIZE, BY PROTEIN BIOMARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BIOMARKERS MARKET SIZE, BY PROTEIN BIOMARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BIOMARKERS MARKET SIZE, BY PROTEIN BIOMARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BIOMARKERS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BIOMARKERS MARKET SIZE, BY CLINICAL TRIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BIOMARKERS MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BIOMARKERS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BIOMARKERS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BIOMARKERS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BIOMARKERS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BIOMARKERS MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BIOMARKERS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BIOMARKERS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL BIOMARKERS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL BIOMARKERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL BIOMARKERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL BIOMARKERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL BIOMARKERS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL BIOMARKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS BIOMARKERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 164. EUROPE BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. EUROPE BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2032 (USD MILLION)
TABLE 166. EUROPE BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 167. EUROPE BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 168. EUROPE BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 169. EUROPE BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 170. EUROPE BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 171. EUROPE BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 172. EUROPE BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 173. EUROPE BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2032 (USD MILLION)
TABLE 174. EUROPE BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. EUROPE BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. AFRICA BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. AFRICA BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2032 (USD MILLION)
TABLE 190. AFRICA BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 191. AFRICA BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 192. AFRICA BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 193. AFRICA BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 194. AFRICA BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 195. AFRICA BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 196. AFRICA BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 197. AFRICA BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2032 (USD MILLION)
TABLE 198. AFRICA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. AFRICA BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. GLOBAL BIOMARKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 213. ASEAN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. ASEAN BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2032 (USD MILLION)
TABLE 215. ASEAN BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 216. ASEAN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 217. ASEAN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 218. ASEAN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 219. ASEAN BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 220. ASEAN BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 221. ASEAN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 222. ASEAN BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2032 (USD MILLION)
TABLE 223. ASEAN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 224. ASEAN BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 225. GCC BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. GCC BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2032 (USD MILLION)
TABLE 227. GCC BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 228. GCC BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 229. GCC BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 230. GCC BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 231. GCC BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 232. GCC BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 233. GCC BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 234. GCC BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2032 (USD MILLION)
TABLE 235. GCC BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 236. GCC BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 249. BRICS BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. BRICS BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2032 (USD MILLION)
TABLE 251. BRICS BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 252. BRICS BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 253. BRICS BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 254. BRICS BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 255. BRICS BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 256. BRICS BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 257. BRICS BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 258. BRICS BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2032 (USD MILLION)
TABLE 259. BRICS BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 260. BRICS BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 261. G7 BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. G7 BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2032 (USD MILLION)
TABLE 263. G7 BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 264. G7 BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 265. G7 BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 266. G7 BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 267. G7 BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 268. G7 BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 269. G7 BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 270. G7 BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2032 (USD MILLION)
TABLE 271. G7 BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 272. G7 BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 273. NATO BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 274. NATO BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2032 (USD MILLION)
TABLE 275. NATO BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 276. NATO BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 277. NATO BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 278. NATO BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 279. NATO BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 280. NATO BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 281. NATO BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 282. NATO BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2032 (USD MILLION)
TABLE 283. NATO BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 284. NATO BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 285. GLOBAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 286. UNITED STATES BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2032 (USD MILLION)
TABLE 288. UNITED STATES BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 289. UNITED STATES BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 290. UNITED STATES BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 291. UNITED STATES BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 292. UNITED STATES BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 293. UNITED STATES BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 294. UNITED STATES BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 295. UNITED STATES BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2032 (USD MILLION)
TABLE 296. UNITED STATES BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 297. UNITED STATES BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 298. CHINA BIOMARKERS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 299. CHINA BIOMARKERS MARKET SIZE, BY BIOMARKER SOURCE, 2018-2032 (USD MILLION)
TABLE 300. CHINA BIOMARKERS MARKET SIZE, BY BLOOD, 2018-2032 (USD MILLION)
TABLE 301. CHINA BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 302. CHINA BIOMARKERS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 303. CHINA BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
TABLE 304. CHINA BIOMARKERS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 305. CHINA BIOMARKERS MARKET SIZE, BY SEQUENCING, 2018-2032 (USD MILLION)
TABLE 306. CHINA BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2032 (USD MILLION)
TABLE 307. CHINA BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2032 (USD MILLION)
TABLE 308. CHINA BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 309. CHINA BIOMARKERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Biomarkers market report include:
  • Abbott Laboratories
  • Alto Neuroscience,Inc.
  • APIS Assay Technologies Limited
  • Augurex Life Sciences Corp
  • Bio-Rad Laboratories, Inc.
  • BioAgilytix
  • Biocrates Life Sciences AG
  • Biofourmis Inc.
  • Biognosys AG
  • BIOINFRA Life Science Inc.
  • BioStarks
  • BioVision Inc.
  • Charles River Laboratories, Inc.
  • Clarigent Corporation
  • EKF Diagnostics Holdings PLC
  • Elo Health, Inc.
  • F. Hoffmann-La Roche, Ltd.
  • Merck KgaA
  • Nightingale Health Plc
  • Owkin Inc.
  • Owlstone Medical Limited
  • PerkinElmer, Inc.
  • Personalis, Inc.
  • Proteomedix AG
  • QIAGEN GmbH
  • Renalytix PLC
  • Siemens Healthcare GmbH
  • Sino Biological Inc.
  • Thermo Fisher Scientific, Inc.
  • VivoSense, Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 77.73 Billion
Forecasted Market Value ( USD ) by 2032 $ 178.08 Billion
Compound Annual Growth Rate14.7%
Regions CoveredGlobal
No. of Companies Mentioned31

Related Topics

Related Reports

Biomarkers Market Report by Product, Type, Disease, Application, End User, and Region 2025-2033 - Product Image

Biomarkers Market Report by Product, Type, Disease, Application, End User, and Region 2025-2033

  • Report
  • 138 Pages
  • Global
From
United States Biomarkers Market Report 2025-2034 - Product Image

United States Biomarkers Market Report 2025-2034

  • Report
  • 250 Pages
  • United States
From
Speech Biomarkers Market - Global Strategic Business Report - Product Image

Speech Biomarkers Market - Global Strategic Business Report

  • Report
  • 283 Pages
  • Global
From
Brain Biomarkers Market - Global Forecast 2026-2032 - Product Image

Brain Biomarkers Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Genomic Biomarker Market - Global Forecast 2026-2032 - Product Image

Genomic Biomarker Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From

About the Biomarkers Market

Metabolomics biomarkers are a type of biomarker used to measure and analyze the metabolites present in a biological sample. Metabolites are small molecules that are produced as a result of metabolic processes, and they can provide valuable information about the health of an individual. Metabolomics biomarkers are used to identify and quantify metabolites in order to gain insight into the metabolic pathways of an organism. This information can be used to diagnose diseases, monitor the progression of a disease, and evaluate the effectiveness of treatments. Metabolomics biomarkers are used in a variety of fields, including drug discovery, toxicology, nutrition, and personalized medicine. They are also used to identify biomarkers for diseases such as cancer, diabetes, and cardiovascular disease. Companies in the metabolomics biomarker market include Metabolon, Biocrates Life Sciences, Metabolomic Technologies, Metabolon, and Metabolomics Technologies. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.